Short answer:
The excerpt you shared does not contain the specific fullâyear guidance for net income or net profit margin, so those figures canât be quoted directly from the information provided.
Why the guidance isnât in the snippet
- The summary focuses on Q2â2025 operating results (net sales, grossâmargin, a Chinaâspecific inventory pullâback, etc.).
- The language â... due to planned reduction of channel inventory in Chinaâ stops abruptly, indicating that the rest of the pressârelease (which would normally contain the companyâs FYâ2025 outlook) has been cut off.
- In a typical STAAR Surgical earnings release, the fullâyear outlook appears in a separate âOutlook / Guidanceâ paragraph that follows the financial tables. That paragraph is not included in the text you posted.
What you can infer (but not quote)
Even though the exact numbers are missing, a few clues let us sketch the likely direction of the fullâyear outlook:
| Indicator | Observation from Q2â2025 | Likely implication for FYâ2025 |
|---|---|---|
| Net sales | $44.3âŻM (â55âŻ% YoY) driven by a planned inventory reduction in China. ExâChina sales were $39.0âŻM, up 10âŻ% YoY. | The sharp Chinaârelated dip will pull down total FY sales versus the prior year, though the upside outside China may offset some of the headâcount loss. |
| Gross margin | 74.0âŻ% vs. 79.2âŻ% a year earlier (â5.2âŻpts). The decline is attributed to the inventoryâclearance effort (likely higher costâofâgoods or lower pricing on the China channel). | A lower grossâmargin in Q2 suggests the FY grossâmargin will settle below the priorâyear level, unless the China inventory issue is fully resolved later in the year. |
| Operating expense trend | Not disclosed in the excerpt, but historically STAARâs SG&A and R&D are fairly stable as a share of sales. | If operating expenses stay roughly flat while sales drop, operating profit (and thus net income) will be squeezed. |
| Management commentary (typical in a full release) | Usually includes a statement such as âWe continue to expect FYâ2025 net income in the range of $Xâ$Y million, representing a net profit margin of ZâŻ%.â | The actual numbers would be provided there, but we can only say that they are expected to be lower than FYâ2024 because of the inventory writeâdown in China and the margin compression seen in Q2. |
Bottom line
- Projected net income: The press release you cited does not reveal a specific FYâ2025 netâincome figure. Because the headline Q2 results show a 55âŻ% drop in total sales and a 5âpoint decline in gross margin, it is reasonable to expect FYâ2025 net income to be materially lower than FYâ2024, unless the company can recoup the Chinese inventory dip later in the year.
- Projected net profit margin: Likewise, the fullâyear net profit margin is not disclosed in the excerpt. The Q2 grossâmargin contraction from 79.2âŻ% to 74.0âŻ% suggests the FYâ2025 margin will also be lower than the priorâyear level.
What to do next
To obtain the precise guidance figures you need, consult the complete STAAR Surgical Q2â2025 earnings release (usually posted on the companyâs investorârelations website or on the Business Wire full article). Look for a paragraph titled âOutlook,â âGuidance,â or âManagement Commentaryâ where the company states something similar to:
âFor the full year 2025, we anticipate net income of $âŻXâŻmillion to $âŻYâŻmillion, which would translate to a net profit margin of ZâŻ%.â
If you have access to that full release, feel free to paste the missing portion, and I can instantly extract and interpret the exact numbers for you.